Guidance for Industry; Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
FDA-1998-D-0019-0003Other
Comments
10
Last activity May 24, 2026
Deadline
--
Net supportiSupport minus oppose · campaigns included
+40%
+40% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Guidance for Industry; Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
- Posted
- Oct 11, 2006
- Comment period
- Oct 11, 2006 – ?
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
+40%
Net support
Support5Oppose1Other4
Aggregates include form-letter campaigns. Excluding them, net support is +40% across organic comments.
Who commented
Breakdown by commenter type.
Individual
9
Trade association
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Oct 11, 2006
Jul 11Dec 9Dec 23Jun 23Oct 13Dec 29May 18
Support5Oppose1Other4
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
44%
11%
44%
Trade association
100%
0%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.